1. Home
  2. LGND vs EYE Comparison

LGND vs EYE Comparison

Compare LGND & EYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • EYE
  • Stock Information
  • Founded
  • LGND 1987
  • EYE 1990
  • Country
  • LGND United States
  • EYE United States
  • Employees
  • LGND N/A
  • EYE N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • EYE Ophthalmic Goods
  • Sector
  • LGND Health Care
  • EYE Health Care
  • Exchange
  • LGND Nasdaq
  • EYE Nasdaq
  • Market Cap
  • LGND 2.0B
  • EYE 1.8B
  • IPO Year
  • LGND 1992
  • EYE 2017
  • Fundamental
  • Price
  • LGND $124.30
  • EYE $25.26
  • Analyst Decision
  • LGND Strong Buy
  • EYE Buy
  • Analyst Count
  • LGND 8
  • EYE 9
  • Target Price
  • LGND $144.71
  • EYE $20.11
  • AVG Volume (30 Days)
  • LGND 139.7K
  • EYE 2.4M
  • Earning Date
  • LGND 08-05-2025
  • EYE 08-06-2025
  • Dividend Yield
  • LGND N/A
  • EYE N/A
  • EPS Growth
  • LGND N/A
  • EYE N/A
  • EPS
  • LGND N/A
  • EYE N/A
  • Revenue
  • LGND $181,488,000.00
  • EYE $1,850,850,000.00
  • Revenue This Year
  • LGND $18.41
  • EYE $7.28
  • Revenue Next Year
  • LGND $18.87
  • EYE $3.02
  • P/E Ratio
  • LGND N/A
  • EYE N/A
  • Revenue Growth
  • LGND 53.40
  • EYE 4.31
  • 52 Week Low
  • LGND $81.74
  • EYE $9.56
  • 52 Week High
  • LGND $129.90
  • EYE $25.50
  • Technical
  • Relative Strength Index (RSI)
  • LGND 64.68
  • EYE 72.12
  • Support Level
  • LGND $120.68
  • EYE $24.24
  • Resistance Level
  • LGND $127.07
  • EYE $25.39
  • Average True Range (ATR)
  • LGND 3.76
  • EYE 0.84
  • MACD
  • LGND 0.86
  • EYE -0.04
  • Stochastic Oscillator
  • LGND 81.95
  • EYE 92.60

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About EYE National Vision Holdings Inc.

National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.

Share on Social Networks: